Search

Author/Creator van den Hout, Mari FCM

1. Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials. (4th November 2015)

Authors:
de Gruijl, Tanja D; Koster, Bas D; van den Hout, Mari FCM; Sluijter, Berbel JR; Molenkamp, Barbara G; Vuylsteke, Ronald JCLM; van Leeuwen, Paul AM; Scheper, Rik J; van den Tol, Petrousjka; van den Eertwegh, Alfons
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment. Issue 3 (18th March 2021)

Authors:
Koster, Bas D; López González, Marta; van den Hout, Mari FCM; Turksma, Annelies W; Sluijter, Berbel JR; Molenkamp, Barbara G; van Leeuwen, Paul AM; Vosslamber, Saskia; Scheper, Rik J; van den Eertwegh, Alfons JM; van den Tol, M Petrousjka; Jordanova, Ekaterina J; de Gruijl, Tanja D
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search